How best to diagnose and control asthma in the elderly

Journal of Respiratory Diseases

Volumn 27, Issue 6, 2006, Pages 238-247

  King, Monroe James ^a   Lockey, Richard F ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Asthma; Geriatrics

Indexed keywords

ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN NATRIURETIC PEPTIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEVALBUTEROL; MONTELUKAST; NEDOCROMIL; OMALIZUMAB; SALBUTAMOL; THEOPHYLLINE; ZAFIRLUKAST; ZILEUTON;

AGITATION; ALLERGIC RHINITIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; COUGHING; DEATH; DYSPNEA; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; LEISURE; LUNG FUNCTION; METERED DOSE INHALER; QUALITY OF LIFE; REVIEW; SEIZURE; SIDE EFFECT; SPIROMETRY; SUBCAPSULAR CATARACT; TACHYCARDIA; THORAX RADIOGRAPHY; VOCAL CORD DISORDER; WHEEZING;

EID: 33750355553     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Enright PL, McClelland RL, Newman, AB, et al. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest. 1999;116:603-613.
2. Zaas D, Wise R, Wiener C; Longcope Spirometry Investigation Team. Airway obstruction is common but unsuspected in patients admitted to a general medicine service, Chest. 2004;125:106-111.
3. Hartert TV, Togias A, Mellen BG, et al. Underutilization of controller and rescue medications among older adults with asthma requiring hospital care. J Am Geriatr Soc. 2000;48:651-657.
4. Reed CE. The role of allergy and airway inflammation. In: Barbee RA, Bloom JW, eds. Asthma in the Elderly. New York: Marcel Dekker, Inc; 1997:33-51.
5. Burrows B, Lebowitz MD, Barbee RA, Cline MG. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample. J Allergy Clin Immunol. 1991;88:870-877.
6. King MJ, Bukantz S, Phillips S, et al. Serum total IgE and specific IgE to Dermatophagoides pteronyssinus, but not eosinophil cationic protein, are more likely to be elevated in elderly asthmatic patients. Allergy Asthma Proc. 2004;25:321-325.
7. Rogers L, Cassino C, Berger KI, et al. Asthma in the elderly: cockroach sensitization and severity of airway obstruction in elderly nonsmokers. Chest. 2002;122:1580-1586.
8. National Institutes of Health. Global Strategy for Asthma Management and Prevention. NIH publication 02-3659; January 1995, updated 2002. Management Segment (chapter 7); 2003. updated 2004. Available at: www. ginasthmaorg. Accessed October 17, 2005.
9. S. Tamulis T. Association between area socioeconomic status and hospital admissions for childhood and adult asthma [doctoral thesis]. Tampa, Fla: University of South Florida College of Public Health; 2004.
10. National Asthma Education and Prevention Program Working Group Report: Considerations for Diagnosing and Managing Asthma in the Elderly. Bethesda, Md: National Institutes of Health; February 1996. NIH publication 96-3662.
11. National Heart, Lung, and Blood Institute Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health; April 1997. NIH publication 97-4051.
12. National Asthma Education and Prevention Program Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics. Bethesda, Md: National Institutes of Health; May 2003. NIH publication 02-5075.
13. Pocket Guide for Asthma Management and Prevention: A Pocket Guide for Physicians and Nurses. From the NHLBI/WHO Workshop Report Global Strategy for Asthma Management and Prevention. National Heart, Lung, and Blood Institute/World Health Organization; January 1995. Revised 2002, updated 2005.
14. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004;125:2309-2321.
15. Ihre E, Zetterström O, Ihre E, Hammarberg B. Voice problems as side effects of inhaled corticosteroids in asthma patients - a prevalence study. J Voice. 2004;18:403-414.
16. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159:941-955.
17. FDA public health advisory. Issued November 18, 2005. Available at: www.fda.gov/cder/ drug/advisory/LABA.htm. Accessed April 4, 2006.
18. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170:836-844.
19. Evans DJ, Taylor DA, Zetterström O, et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med. 1997;337:1412-1418.
20. Ito K, Lim S, Caramori G, et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA. 2002;99:8921-8926.
21. Ohta K, Fukuchi Y, Grouse L, et al. A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD. Respir Med. 2004;98:1016-1024.
22. Korenblat PE, Kemp JP, Scherger JE, et al. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol. 2000;84:217-225.